Gilmour, Susan

Susan Gilmour, PHD

Resident Faculty

Dr. Gilmour is defining mechanisms by which tumor modifiers, such as polyamines and thrombin, support and accelerate the development of cancer to a malignant, metastatic state. She is also investigating how polyamines recruit mutant stem cell populations to promote the early development of tumors. The goal is to translate these basic research findings to novel polyamine- or thrombin-targeted therapies that can contribute to increased survival in cancer patients.

  • 2001–Present: Professor, Lankenau Institute for Medical Research
  • 2018–Present: Deputy Director, Lankenau Institute for Medical Research
  • 2000–Present: Associate Professor, Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel College of Medicine,Thomas Jefferson University
  • 2004–Present: Adjunct Professor of Graduate Biology, St. Joseph's University, Philadelphia
  • 2006–Present: Adjunct Professor of Pathology, Drexel University, Philadelphia
  • 2006–Present: Program in Cell Biology and Signaling, Sidney Kimmel Cancer Center, Thomas Jefferson University
  • 2017: Chair, Polyamines Gordon Conference, "Polyamine Metabolism in Disease and Polyamine-Targeted Therapies"